NERV
Minerva Neurosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$245.06M
P/E Ratio
—
EPS
$-37.03
Beta
-0.10
52W High
$8.80
52W Low
$1.35
50-Day MA
$6.17
200-Day MA
$4.44
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
11.21
PEG Ratio
0.00
About Minerva Neurosciences Inc
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products for the treatment of diseases of the central nervous system. The company is headquartered in Waltham, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-9.65M |
| EBITDA | $-27.87M |
| Operating Margin | 0.00% |
| Return on Equity | -675.00% |
| Return on Assets | -27.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-5.79 |
| Price-to-Book | 2.68 |
| Price-to-Sales (TTM) | 1.87 |
| EV/Revenue | 0.0345 |
| EV/EBITDA | 2.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $46.59M |
| Float | $30.87M |
| % Insiders | 3.34% |
| % Institutions | 89.53% |
Historical Volatility
HV 10-Day
109.62%
HV 20-Day
81.71%
HV 30-Day
79.45%
HV 60-Day
103.95%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($9.50 target)
1
Strong Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026